登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《JAMA，3月4日，Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-05

  • Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient

    Sean Wei Xiang Ong, MBBS1; Yian Kim Tan, PhD2; Po Ying Chia, MBBS1; et alTau Hong Lee, MBBS1; Oon Tek Ng, MBBS, MPH1; Michelle Su Yen Wong, PhD2; Kalisvar Marimuthu, MBBS1

    Author Affiliations Article Information

    JAMA. Published online March 4, 2020. doi:10.1001/jama.2020.3227

    Coronaviruses have been implicated in nosocomial outbreaks1 with environmental contamination as a route of transmission.2 Similarly, nosocomial transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been reported.3 However, the mode of transmission and extent of environmental contamination are unknown.

  • 原文来源：https://jamanetwork.com/journals/jama/fullarticle/2762692?resultClick=1
4浏览量
原文链接
相关报告

  • 《JAMA，4月27日，Exposure to a Surrogate Measure of Contamination From Simulated Patients by Emergency Department Personnel Wearing Personal Protective Equipment》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-04-28
    • Exposure to a Surrogate Measure of Contamination From Simulated Patients by Emergency Department Personnel Wearing Personal Protective Equipment Oren Feldman, MD1; Michal Meir, MD2; Danielle Shavit, BSc3; et alRavit Idelman, MD1; Itai Shavit, MD1 Author Affiliations Article Information JAMA. Published online April 27, 2020. doi:10.1001/jama.2020.6633 A major challenge with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is the effective protection of health care workers.1 Recommendations for the use of personal protective equipment to protect against SARS-CoV-2 exposure by health care workers were recently published by the World Health Organization and the US Centers for Disease Control and Prevention. For aerosol-generating procedures, N95 respirators, eye protection, isolation gowns, and gloves were recommended. Coveralls, boots with a cover, and hair coverings were not part of the recommended protective clothing.2,3 We assessed the protection of emergency physicians and nurses wearing the recommended personal protective equipment while caring for a simulated patient with respiratory distress.
    7浏览量
    原文链接

  • 《JAMA，4月24日，Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-04-25
    • Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial Mayla Gabriela Silva Borba, MD1,2; Fernando Fonseca Almeida Val, PhD1,2; Vanderson Souza Sampaio, PhD1,2,3; et alMarcia Almeida Araújo Alexandre, MD1; Gisely Cardoso Melo, PhD1,2; Marcelo Brito, MSc1,2; Maria Paula Gomes Mourão, MD1,2; José Diego Brito-Sousa, MSc1,2; Djane Baía-da-Silva, PhD1,2; Marcus Vinitius Farias Guerra, MD1; Ludhmila Abrahão Hajjar, MD4; Rosemary Costa Pinto, BSc3; Antonio Alcirley Silva Balieiro, MSc5; Antônio Guilherme Fonseca Pacheco, MD6; James Dean Oliveira Santos Jr, PhD7; Felipe Gomes Naveca, PhD5; Mariana Simão Xavier, MSc8; André Machado Siqueira, MD8; Alexandre Schwarzbold, MD9; Júlio Croda, MD10,11; Maurício Lacerda Nogueira, MD12; Gustavo Adolfo Sierra Romero, MD13; Quique Bassat, MD14,15,16,17,18; Cor Jesus Fontes, MD19; Bernardino Cláudio Albuquerque, MD20; Cláudio-Tadeu Daniel-Ribeiro, MD21; Wuelton Marcelo Monteiro, PhD1,2; Marcus Vinícius Guimarães Lacerda, MD1,2,5; for the CloroCovid-19 Team Author Affiliations JAMA Netw Open. 2020;3(4.23):e208857. doi:10.1001/jamanetworkopen.2020.8857 Abstract Importance There is no specific antiviral therapy recommended for coronavirus disease 2019 (COVID-19). In vitro studies indicate that the antiviral effect of chloroquine diphosphate (CQ) requires a high concentration of the drug. Objective To evaluate the safety and efficacy of 2 CQ dosages in patients with severe COVID-19. Design, Setting, and Participants This parallel, double-masked, randomized, phase IIb clinical trial with 81 adult patients who were hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was conducted from March 23 to April 5, 2020, at a tertiary care facility in Manaus, Brazilian Amazon.
    16浏览量
    原文链接